C07K 14/715
For cytokines
Official title: for cytokines; for lymphokines; for interferons
C07K14/715 (For cytokines) appears on 2,377 US grants and 3,829 published applications in this corpus.
Search patents in C07K- Granted patents
- 2,377
- Published applications
- 3,829
- Assignees
- 1,262
- Inventors
- 5,615
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1986 | 1 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 2 | 0 |
| 1990 | 2 | 0 |
| 1991 | 2 | 0 |
| 1992 | 7 | 0 |
| 1993 | 15 | 0 |
| 1994 | 15 | 0 |
| 1995 | 19 | 0 |
| 1996 | 32 | 0 |
| 1997 | 35 | 0 |
| 1998 | 79 | 0 |
| 1999 | 88 | 0 |
| 2000 | 59 | 0 |
| 2001 | 71 | 14 |
| 2002 | 71 | 171 |
| 2003 | 77 | 192 |
| 2004 | 62 | 137 |
| 2005 | 54 | 145 |
| 2006 | 75 | 120 |
| 2007 | 83 | 170 |
| 2008 | 79 | 101 |
| 2009 | 84 | 130 |
| 2010 | 85 | 113 |
| 2011 | 71 | 112 |
| 2012 | 61 | 81 |
| 2013 | 48 | 83 |
| 2014 | 46 | 100 |
| 2015 | 47 | 87 |
| 2016 | 56 | 97 |
| 2017 | 66 | 106 |
| 2018 | 62 | 149 |
| 2019 | 77 | 146 |
| 2020 | 111 | 183 |
| 2021 | 116 | 227 |
| 2022 | 108 | 235 |
| 2023 | 99 | 261 |
| 2024 | 108 | 266 |
| 2025 | 134 | 237 |
| 2026 | 70 | 166 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Drug-specific pharmacokinetic assay for IL-15 superagonist6 Oct 2026US 12,754,189 B2NantCell, Inc.
- CD5 chimeric antigen receptor for adoptive T cell therapy29 Sep 2026US 12,746,273 B2Baylor College of Medicine
- Efficient non-meiotic allele introgression in livestock1 Sep 2026US 12,721,326 B2Tog Technologies, LLC
- Effective dosages of an adenoviral-based biological delivery and expression system for use in the treatment of osteoarthritis in humans, and compositions comprising the same25 Aug 2026US 12,714,755 B2Pacira Therapeutics, Inc.
- Methods for treating allergy and enhancing allergen-specific immunotherapy by administering an IL-4R antagonist18 Aug 2026US 12,708,666 B2Regeneron Pharmaceuticals, Inc.
- Application of CCR5hi Innate Immune Memory Cells in Preparation of Immunotherapeutic Drug for Treating Sepsis8 Oct 2026US 2026/0306538 A1Children's Hospital of Soochow University
- Chimeric receptors8 Oct 2026US 2026/0306631 A1St. Jude Children?S Research Hospital
- A novel il-15r alpha fc fusion protein and uses thereof8 Oct 2026US 2026/0308234 A1Staidson Biopharma Inc.
- Chimeric Cytokine Receptors and Methods of Use8 Oct 2026US 2026/0308235 A1
- Il12rb2 binding molecules and methods of use8 Oct 2026US 2026/0308265 A1Synthekine, Inc.
Most cited
By later US patents
- Methods of lowering active TNF-.alpha. levels in mammals using tumor necrosis factor receptor301US 5,605,690 AImmunex Corporation · 1997
- DNA encoding a chimeric polypeptide comprising the extracellular domain of TNF receptor fused to IgG, vectors, and host cells271US 5,447,851 ABoard of Regents, The University of Texas System · 1995
- Antibody to human interleukin-6 receptor203US 5,670,373 A1997
- Immunotoxins, comprising an internalizing antibody, directed against malignant and normal cells200US 6,653,104 B2Immunomedics, Inc. · 2003
- Chimeric CTLA4 receptor and methods for its use199US 5,434,131 ABristol-Myers Squibb Company · 1995